Posted by Marty on November 22, 2008, at 15:00:41
In reply to Agomelatine -) 67 days before EMEA decision., posted by CaptainAmerica1967 on November 22, 2008, at 14:37:21
Agomelatine is in phase 3 indeed since a long time. Marketing in the 3rd and 4rd quarter is a possibility, yes.
Btw, www.neurotransmitter.net/newdrugs.html isn't always up to date and sometime wrong. If you're really into following the pipelines status I suggest you don't rely too much on them. It used to be updated frequently but this isn't the case since a couple months. A good example of what I'm talking about is Agomelatine status on their page: Agomelatine is approved and marketed in Ukraine since 2007 on the name Melitor (writen in ukranian.. can't paste the ukrainian here because the site doesn't support those characters but it looks like 'Mentop' in Latin characters) yet there's no mention of it on the page.
> Currently in Phase III in the USA. May not be released in the UK until late 2009.
> Future Treatments for Depression, Anxiety, Sleep Disorders, Psychosis, and ADHD: